{"id":347375,"date":"2025-08-25T11:50:55","date_gmt":"2025-08-25T11:50:55","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-biomarin-pharmaceutical\/"},"modified":"2025-08-25T11:50:55","modified_gmt":"2025-08-25T11:50:55","slug":"how-to-buy-biomarin-pharmaceutical","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biomarin-pharmaceutical\/","title":{"rendered":"BioMarin Pharmaceutical Inc. (BMRN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; BioMarin Pharmaceutical Inc. (BMRN) Hisse Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334117,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-347375","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"BioMarin Pharmaceutical Inc. (BMRN) Hisseleri Nas\u0131l Al\u0131n\u0131r - BioMarin Hisse Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"BioMarin Pharmaceutical Inc. (BMRN) Hisseleri Nas\u0131l Al\u0131n\u0131r - BioMarin Hisse Yat\u0131r\u0131m\u0131"},"description":"Nadir hastal\u0131k tedavisi lideri BioMarin Pharmaceutical (BMRN) hisselerine yat\u0131r\u0131m yapmay\u0131, g\u00fcncel fiyat analizini, 2025-2030 tahminlerini ve ad\u0131m ad\u0131m sat\u0131n alma rehberini \u00f6\u011frenin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Nadir hastal\u0131k tedavisi lideri BioMarin Pharmaceutical (BMRN) hisselerine yat\u0131r\u0131m yapmay\u0131, g\u00fcncel fiyat analizini, 2025-2030 tahminlerini ve ad\u0131m ad\u0131m sat\u0131n alma rehberini \u00f6\u011frenin."},"intro":"Genetik t\u0131p yoluyla hayatlar\u0131 d\u00f6n\u00fc\u015ft\u00fcren bir \u015firkete yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? BioMarin Pharmaceutical (BMRN), nadir hastal\u0131k tedavilerinde \u00f6nc\u00fc konumda olup hem t\u0131bbi at\u0131l\u0131mlar hem de yat\u0131r\u0131m f\u0131rsatlar\u0131 sunmaktad\u0131r. Potansiyel dolu bir \u00fcr\u00fcn hatt\u0131 ve g\u00fc\u00e7l\u00fc finansal performans\u0131yla bu biyoteknoloji lideri, sa\u011fl\u0131k yat\u0131r\u0131mlar\u0131n\u0131n gelece\u011fine a\u00e7\u0131lan kap\u0131n\u0131z olabilir.","intro_source":{"label":"Intro","type":"text","formatted_value":"Genetik t\u0131p yoluyla hayatlar\u0131 d\u00f6n\u00fc\u015ft\u00fcren bir \u015firkete yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? BioMarin Pharmaceutical (BMRN), nadir hastal\u0131k tedavilerinde \u00f6nc\u00fc konumda olup hem t\u0131bbi at\u0131l\u0131mlar hem de yat\u0131r\u0131m f\u0131rsatlar\u0131 sunmaktad\u0131r. Potansiyel dolu bir \u00fcr\u00fcn hatt\u0131 ve g\u00fc\u00e7l\u00fc finansal performans\u0131yla bu biyoteknoloji lideri, sa\u011fl\u0131k yat\u0131r\u0131mlar\u0131n\u0131n gelece\u011fine a\u00e7\u0131lan kap\u0131n\u0131z olabilir."},"body_html":"<h2>\ud83d\udcc8 BioMarin Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2> <p>25 A\u011fustos 2025 itibar\u0131yla BioMarin Pharmaceutical (BMRN) NASDAQ'ta <strong>58,58 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>4 Kas\u0131m 2025<\/strong> kesinlikle kritik\u2014BioMarin'in bir sonraki kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 tarih. Tarihsel olarak, bu raporlar \u00f6nemli fiyat hareketleri yarat\u0131r ve deneyimli yat\u0131r\u0131mc\u0131lar taraf\u0131ndan yak\u0131ndan takip edilir.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 BMRN Hissesini Nas\u0131l Hareket Ettirir<\/h3> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Haber \u00d6ncesi Fiyat<\/th><th>Haber Sonras\u0131 De\u011fi\u015fim<\/th><\/tr> <\/thead> <tbody> <tr><td>4 A\u011fu 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>57,20 $<\/td><td>%2,4 Art\u0131\u015f (g\u00fc\u00e7l\u00fc sonu\u00e7lar)<\/td><\/tr> <tr><td>5 May 2025<\/td><td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>55,80 $<\/td><td>%3,8 Art\u0131\u015f (gelir beklentisi a\u015f\u0131ld\u0131)<\/td><\/tr> <tr><td>6 \u015eub 2025<\/td><td>Y\u0131ll\u0131k Sonu\u00e7lar<\/td><td>53,40 $<\/td><td>%6,2 Art\u0131\u015f (y\u00f6nlendirme y\u00fckseltildi)<\/td><\/tr> <tr><td>5 Kas 2024<\/td><td>3. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>56,10 $<\/td><td>%4,8 D\u00fc\u015f\u00fc\u015f (\u00fcr\u00fcn hatt\u0131 gecikmesi)<\/td><\/tr> <tr><td>6 A\u011fu 2024<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>58,90 $<\/td><td>%1,5 Art\u0131\u015f (istikrarl\u0131 b\u00fcy\u00fcme)<\/td><\/tr> <tr><td>7 May 2024<\/td><td>Sat\u0131n Alma Haberi<\/td><td>54,20 $<\/td><td>%8,3 Art\u0131\u015f (stratejik hamle)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: Pozitif kazan\u00e7 s\u00fcrprizleri genellikle BMRN'yi birka\u00e7 g\u00fcn i\u00e7inde %3-6 oran\u0131nda y\u00fckseltir. 4 A\u011fustos 2025 raporu tam olarak bu modeli g\u00f6sterdi\u2014g\u00fc\u00e7l\u00fc sonu\u00e7lar hemen fiyat art\u0131\u015f\u0131na yol a\u00e7t\u0131.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu (\u015eubat-A\u011fustos 2025)<\/h2> <p>BioMarin hisseleri son alt\u0131 ayda yakla\u015f\u0131k <strong>%30-35<\/strong> oran\u0131nda d\u00fc\u015f\u00fc\u015f ya\u015fad\u0131 ancak son d\u00f6nemde istikrar g\u00f6sterdi:<\/p> <ul> <li><strong>\u015eubat 2025<\/strong>: 85-90 $ aral\u0131\u011f\u0131 (kazan\u00e7 \u00f6ncesi iyimserlik)<\/li> <li><strong>Mart 2025<\/strong>: 78-82 $ (sekt\u00f6r genelinde biyoteknoloji bask\u0131s\u0131)<\/li> <li><strong>Nisan 2025<\/strong>: 72-75 $ (d\u00fczenleyici endi\u015feler)<\/li> <li><strong>May\u0131s 2025<\/strong>: 68-72 $ (sat\u0131n alma entegrasyon a\u015famas\u0131)<\/li> <li><strong>Haziran 2025<\/strong>: 62-65 $ (piyasa volatilitesi)<\/li> <li><strong>Temmuz 2025<\/strong>: 58-61 $ (istikrarl\u0131l\u0131k d\u00f6nemi)<\/li> <li><strong>A\u011fustos 2025<\/strong>: 58,58 $ (mevcut konsolidasyon)<\/li> <\/ul> <p><strong>Neden volatilite?<\/strong> <a href=\"https:\/\/investors.biomarin.com\/financials\/quarterly-results\/default.aspx\">G\u00fc\u00e7l\u00fc 2. \u00c7eyrek 2025 sonu\u00e7lar\u0131 ve y\u00fckseltilmi\u015f y\u00f6nlendirme<\/a> rapor edilmesine ra\u011fmen, BioMarin daha geni\u015f biyoteknoloji sekt\u00f6r\u00fc r\u00fczgarlar\u0131 ve d\u00fczenleyici belirsizliklerle kar\u015f\u0131la\u015ft\u0131. \u015eirketin <a href=\"https:\/\/www.biomarin.com\/news\/press-releases\/biomarin-reports-fourth-quarter-and-full-year-2024-results-sets-full-year-2025-guidance\/\">temel performans\u0131 g\u00fc\u00e7l\u00fc kald\u0131<\/a> ve gelir b\u00fcy\u00fcmesi beklentileri a\u015ft\u0131.<\/p> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <ul> <li><strong>2025 Y\u0131l Sonu<\/strong>: 65-75 $ (mevcut analist konsens\u00fcs\u00fc ve \u00fcr\u00fcn hatt\u0131 kataliz\u00f6rlerine dayanarak) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><\/li> <li><strong>2026 Tahmini<\/strong>: 80-95 $ (sat\u0131n alma sinerjileri ve pazar geni\u015flemesi)<\/li> <li><strong>2028 Projeksiyonu<\/strong>: 110-130 $ (\u00fcr\u00fcn hatt\u0131 olgunla\u015fmas\u0131 ve k\u00fcresel penetrasyon)<\/li> <li><strong>2030 Vizyonu<\/strong>: 140-170 $ (nadir hastal\u0131k pazar liderli\u011fi ve yeni terapi lansmanlar\u0131)<\/li> <\/ul> <p><strong>Sonu\u00e7<\/strong>: BioMarin, cazip bir <strong>uzun vadeli yat\u0131r\u0131m f\u0131rsat\u0131<\/strong> sunmaktad\u0131r. Mevcut fiyat, 3 y\u0131ll\u0131k dip seviyelere yak\u0131n olup sab\u0131rl\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in m\u00fckemmel giri\u015f noktalar\u0131 sa\u011flar.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Pozitif \u0130\u015faretler<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>D\u00fczenleyici belirsizlik<\/strong>: <a href=\"https:\/\/www.tipranks.com\/stocks\/bmrn\/risk-factors\">Avrupa Komisyonu'nun \u00f6nerdi\u011fi ila\u00e7 mevzuat\u0131 de\u011fi\u015fiklikleri<\/a> veri m\u00fcnhas\u0131rl\u0131k s\u00fcrelerini azaltabilir<\/li> <li><strong>Klinik deneme gecikmeleri<\/strong>: BMN 333 veya BMN 351 geli\u015fimindeki herhangi bir gecikme b\u00fcy\u00fcme projeksiyonlar\u0131n\u0131 etkileyebilir<\/li> <li><strong>Rekabet bask\u0131s\u0131<\/strong>: Sanofi'nin Genzyme ve Ultragenyx Pharmaceutical gibi iyi finanse edilen rakiplerle kar\u015f\u0131 kar\u015f\u0131ya<\/li> <li><strong>Fiyatland\u0131rma incelemesi<\/strong>: Artan k\u00fcresel ila\u00e7 fiyatland\u0131rmas\u0131 oda\u011f\u0131 k\u00e2rl\u0131l\u0131\u011f\u0131 etkileyebilir<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>G\u00fc\u00e7l\u00fc finansallar<\/strong>: <a href=\"https:\/\/stockanalysis.com\/stocks\/bmrn\/forecast\/\">2. \u00c7eyrek 2025 gelir beklentisi 62 milyon $ a\u015f\u0131ld\u0131<\/a> ve hisse ba\u015f\u0131na kazan\u00e7 tahminleri 0,51 $ ge\u00e7ti<\/li> <li><strong>\u00dcr\u00fcn hatt\u0131 ilerlemesi<\/strong>: Pozitif Faz 3 PALYNZIQ sonu\u00e7lar\u0131 ve tamamlanm\u0131\u015f VOXZOGO kayd\u0131<\/li> <li><strong>Stratejik sat\u0131n alma<\/strong>: 270 milyon $ de\u011ferinde Inozyme Pharma al\u0131m\u0131, enzim tedavisi portf\u00f6y\u00fcn\u00fc geni\u015fletti<\/li> <li><strong>Analist g\u00fcveni<\/strong>: <a href=\"https:\/\/www.directorstalkinterviews.com\/biomarin-pharmaceutical-inc-bmrn-stock-analysis-a-65-upside-potential-with-strong-buy-ratings\/4121210620\">22 analist AL \u00f6nerisini s\u00fcrd\u00fcr\u00fcyor<\/a> ve ortalama hedef fiyat 93,14 $<\/li> <li><strong>Sekt\u00f6r r\u00fczgarlar\u0131<\/strong>: Nadir hastal\u0131k tedavi pazar\u0131 y\u0131ll\u0131k %12 b\u00fcy\u00fcyor<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir Yat\u0131r\u0131mc\u0131 Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %2-5'ini temsil eden bir pozisyonla ba\u015flay\u0131n\u2014biyoteknoloji dikkatli risk y\u00f6netimi gerektirir<\/li> <li><strong>Dolar maliyeti ortalamas\u0131 yap\u0131n<\/strong>: Volatilite s\u0131ras\u0131nda zamanlama hatalar\u0131n\u0131 \u00f6nlemek i\u00e7in ayl\u0131k sabit tutarlarda yat\u0131r\u0131m yap\u0131n<\/li> <li><strong>Fiyat uyar\u0131lar\u0131 kurun<\/strong>: 4 Kas\u0131m kazan\u00e7lar\u0131 \u00e7evresinde BMRN'yi izleyin\u2014rapor sonras\u0131 %5-8 d\u00fc\u015f\u00fc\u015fte al\u0131m yap\u0131n<\/li> <li><strong>Uzun vadeli d\u00fc\u015f\u00fcn\u00fcn<\/strong>: BioMarin'in de\u011feri haftalar de\u011fil y\u0131llar i\u00e7inde ortaya \u00e7\u0131kar<\/li> <\/ol> <p><em>Mizahi deneyimli yat\u0131r\u0131mc\u0131 bilgeli\u011fi: \"BMRN ticareti, boya kurumas\u0131n\u0131 izlemek gibidir\u2014ta ki \u00f6yle olmad\u0131\u011f\u0131 ana kadar. Biyoteknoloji sabr\u0131 oyunu amat\u00f6rleri, daha iyi boya alabilenlerden ay\u0131r\u0131r.\"<\/em><\/p> <h2>\u2705 BioMarin Pharmaceutical Inc. (BMRN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir ticaret platformu se\u00e7in<\/td><td>NASDAQ eri\u015fimi ve makul \u00fccretler sundu\u011fundan emin olun<\/td><\/tr> <tr><td>2<\/td><td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td><td>Gerekli belgeleri sa\u011flay\u0131n\u2014genellikle 1-3 g\u00fcn s\u00fcrer<\/td><\/tr> <tr><td>3<\/td><td>Fon yat\u0131r\u0131n<\/td><td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>4<\/td><td>G\u00fcncel fiyat\u0131 ara\u015ft\u0131r\u0131n<\/td><td>Sipari\u015f vermeden \u00f6nce BMRN'nin ger\u00e7ek zamanl\u0131 fiyat\u0131n\u0131 kontrol edin<\/td><\/tr> <tr><td>5<\/td><td>Sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in<\/td><td>Giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td><\/tr> <tr><td>6<\/td><td>Hisse miktar\u0131n\u0131 girin<\/td><td>K\u00fc\u00e7\u00fck ba\u015fl\u0131yorsan\u0131z kesirli hisseleri d\u00fc\u015f\u00fcn\u00fcn<\/td><\/tr> <tr><td>7<\/td><td>\u0130nceleyin ve onaylay\u0131n<\/td><td>\u0130\u015flem \u00f6ncesi sipari\u015f detaylar\u0131n\u0131 \u00e7ift kontrol edin<\/td><\/tr> <tr><td>8<\/td><td>Pozisyonunuzu izleyin<\/td><td>Fiyat hareketleri ve haberler i\u00e7in uyar\u0131lar kurun<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Uygun?<\/h2> <p>Pocket Option, hisse senedi yat\u0131r\u0131m\u0131n\u0131 herkes i\u00e7in eri\u015filebilir k\u0131lar:<\/p> <ul> <li><strong>Minimum depozito sadece 5 $<\/strong> \u2014 stratejileri d\u00fc\u015f\u00fck riskle test etmek i\u00e7in m\u00fckemmel<\/li> <li><strong>\u015eim\u015fek h\u0131z\u0131nda do\u011frulama<\/strong> \u2014 herhangi bir resmi kimlikle dakikalar i\u00e7inde ticarete ba\u015flay\u0131n<\/li> <li><strong>100'den fazla para \u00e7ekme y\u00f6ntemi<\/strong> \u2014 kripto paralar, e-c\u00fczdanlar ve banka transferleri dahil<\/li> <li><strong>Kullan\u0131c\u0131 dostu platform<\/strong> \u2014 piyasalar\u0131 \u00f6\u011frenen yeni ba\u015flayanlar i\u00e7in sezgisel aray\u00fcz<\/li> <\/ul> <h2>\ud83c\udf0d 2025'te BioMarin: Nadir Hastal\u0131k \u00d6nc\u00fcs\u00fc<\/h2> <p>BioMarin, yedi onayl\u0131 terapi ve sa\u011flam bir \u00fcr\u00fcn hatt\u0131yla nadir genetik hastal\u0131k tedavi pazar\u0131nda hakimdir. \u015eirketin d\u00fcnya \u00e7ap\u0131nda 5.000'den az hastay\u0131 etkileyen durumlara odaklanmas\u0131 do\u011fal tekel ve fiyatland\u0131rma g\u00fcc\u00fc yarat\u0131r. Yak\u0131n zamanda yapt\u0131\u011f\u0131 <a href=\"https:\/\/www.biomarin.com\/company\/\">270 milyon $ de\u011ferindeki Inozyme Pharma sat\u0131n al\u0131m\u0131<\/a>, enzim replasman tedavilerine agresif geni\u015flemeyi g\u00f6stermektedir.<\/p> <p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: BioMarin bilim insanlar\u0131, CLN2 tedavisinin sadece hastal\u0131k ilerlemesini yava\u015flatmakla kalmay\u0131p, ayn\u0131 zamanda genetik n\u00f6rolojik bozukluklarda daha \u00f6nce imkans\u0131z oldu\u011fu d\u00fc\u015f\u00fcn\u00fclen sinirsel rejenerasyon belirtileri g\u00f6sterdi\u011fini ke\u015ffettiler. Bu at\u0131l\u0131m, nadir hastal\u0131k tedavisine yakla\u015f\u0131m\u0131m\u0131z\u0131 devrim niteli\u011finde de\u011fi\u015ftirebilir.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 BioMarin Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2>\n<p>25 A\u011fustos 2025 itibar\u0131yla BioMarin Pharmaceutical (BMRN) NASDAQ&#8217;ta <strong>58,58 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>4 Kas\u0131m 2025<\/strong> kesinlikle kritik\u2014BioMarin&#8217;in bir sonraki kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 tarih. Tarihsel olarak, bu raporlar \u00f6nemli fiyat hareketleri yarat\u0131r ve deneyimli yat\u0131r\u0131mc\u0131lar taraf\u0131ndan yak\u0131ndan takip edilir.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 BMRN Hissesini Nas\u0131l Hareket Ettirir<\/h3>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>4 A\u011fu 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>57,20 $<\/td>\n<td>%2,4 Art\u0131\u015f (g\u00fc\u00e7l\u00fc sonu\u00e7lar)<\/td>\n<\/tr>\n<tr>\n<td>5 May 2025<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>55,80 $<\/td>\n<td>%3,8 Art\u0131\u015f (gelir beklentisi a\u015f\u0131ld\u0131)<\/td>\n<\/tr>\n<tr>\n<td>6 \u015eub 2025<\/td>\n<td>Y\u0131ll\u0131k Sonu\u00e7lar<\/td>\n<td>53,40 $<\/td>\n<td>%6,2 Art\u0131\u015f (y\u00f6nlendirme y\u00fckseltildi)<\/td>\n<\/tr>\n<tr>\n<td>5 Kas 2024<\/td>\n<td>3. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>56,10 $<\/td>\n<td>%4,8 D\u00fc\u015f\u00fc\u015f (\u00fcr\u00fcn hatt\u0131 gecikmesi)<\/td>\n<\/tr>\n<tr>\n<td>6 A\u011fu 2024<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>58,90 $<\/td>\n<td>%1,5 Art\u0131\u015f (istikrarl\u0131 b\u00fcy\u00fcme)<\/td>\n<\/tr>\n<tr>\n<td>7 May 2024<\/td>\n<td>Sat\u0131n Alma Haberi<\/td>\n<td>54,20 $<\/td>\n<td>%8,3 Art\u0131\u015f (stratejik hamle)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: Pozitif kazan\u00e7 s\u00fcrprizleri genellikle BMRN&#8217;yi birka\u00e7 g\u00fcn i\u00e7inde %3-6 oran\u0131nda y\u00fckseltir. 4 A\u011fustos 2025 raporu tam olarak bu modeli g\u00f6sterdi\u2014g\u00fc\u00e7l\u00fc sonu\u00e7lar hemen fiyat art\u0131\u015f\u0131na yol a\u00e7t\u0131.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu (\u015eubat-A\u011fustos 2025)<\/h2>\n<p>BioMarin hisseleri son alt\u0131 ayda yakla\u015f\u0131k <strong>%30-35<\/strong> oran\u0131nda d\u00fc\u015f\u00fc\u015f ya\u015fad\u0131 ancak son d\u00f6nemde istikrar g\u00f6sterdi:<\/p>\n<ul>\n<li><strong>\u015eubat 2025<\/strong>: 85-90 $ aral\u0131\u011f\u0131 (kazan\u00e7 \u00f6ncesi iyimserlik)<\/li>\n<li><strong>Mart 2025<\/strong>: 78-82 $ (sekt\u00f6r genelinde biyoteknoloji bask\u0131s\u0131)<\/li>\n<li><strong>Nisan 2025<\/strong>: 72-75 $ (d\u00fczenleyici endi\u015feler)<\/li>\n<li><strong>May\u0131s 2025<\/strong>: 68-72 $ (sat\u0131n alma entegrasyon a\u015famas\u0131)<\/li>\n<li><strong>Haziran 2025<\/strong>: 62-65 $ (piyasa volatilitesi)<\/li>\n<li><strong>Temmuz 2025<\/strong>: 58-61 $ (istikrarl\u0131l\u0131k d\u00f6nemi)<\/li>\n<li><strong>A\u011fustos 2025<\/strong>: 58,58 $ (mevcut konsolidasyon)<\/li>\n<\/ul>\n<p><strong>Neden volatilite?<\/strong> <a href=\"https:\/\/investors.biomarin.com\/financials\/quarterly-results\/default.aspx\">G\u00fc\u00e7l\u00fc 2. \u00c7eyrek 2025 sonu\u00e7lar\u0131 ve y\u00fckseltilmi\u015f y\u00f6nlendirme<\/a> rapor edilmesine ra\u011fmen, BioMarin daha geni\u015f biyoteknoloji sekt\u00f6r\u00fc r\u00fczgarlar\u0131 ve d\u00fczenleyici belirsizliklerle kar\u015f\u0131la\u015ft\u0131. \u015eirketin <a href=\"https:\/\/www.biomarin.com\/news\/press-releases\/biomarin-reports-fourth-quarter-and-full-year-2024-results-sets-full-year-2025-guidance\/\">temel performans\u0131 g\u00fc\u00e7l\u00fc kald\u0131<\/a> ve gelir b\u00fcy\u00fcmesi beklentileri a\u015ft\u0131.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<ul>\n<li><strong>2025 Y\u0131l Sonu<\/strong>: 65-75 $ (mevcut analist konsens\u00fcs\u00fc ve \u00fcr\u00fcn hatt\u0131 kataliz\u00f6rlerine dayanarak) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><\/li>\n<li><strong>2026 Tahmini<\/strong>: 80-95 $ (sat\u0131n alma sinerjileri ve pazar geni\u015flemesi)<\/li>\n<li><strong>2028 Projeksiyonu<\/strong>: 110-130 $ (\u00fcr\u00fcn hatt\u0131 olgunla\u015fmas\u0131 ve k\u00fcresel penetrasyon)<\/li>\n<li><strong>2030 Vizyonu<\/strong>: 140-170 $ (nadir hastal\u0131k pazar liderli\u011fi ve yeni terapi lansmanlar\u0131)<\/li>\n<\/ul>\n<p><strong>Sonu\u00e7<\/strong>: BioMarin, cazip bir <strong>uzun vadeli yat\u0131r\u0131m f\u0131rsat\u0131<\/strong> sunmaktad\u0131r. Mevcut fiyat, 3 y\u0131ll\u0131k dip seviyelere yak\u0131n olup sab\u0131rl\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in m\u00fckemmel giri\u015f noktalar\u0131 sa\u011flar.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Pozitif \u0130\u015faretler<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>D\u00fczenleyici belirsizlik<\/strong>: <a href=\"https:\/\/www.tipranks.com\/stocks\/bmrn\/risk-factors\">Avrupa Komisyonu&#8217;nun \u00f6nerdi\u011fi ila\u00e7 mevzuat\u0131 de\u011fi\u015fiklikleri<\/a> veri m\u00fcnhas\u0131rl\u0131k s\u00fcrelerini azaltabilir<\/li>\n<li><strong>Klinik deneme gecikmeleri<\/strong>: BMN 333 veya BMN 351 geli\u015fimindeki herhangi bir gecikme b\u00fcy\u00fcme projeksiyonlar\u0131n\u0131 etkileyebilir<\/li>\n<li><strong>Rekabet bask\u0131s\u0131<\/strong>: Sanofi&#8217;nin Genzyme ve Ultragenyx Pharmaceutical gibi iyi finanse edilen rakiplerle kar\u015f\u0131 kar\u015f\u0131ya<\/li>\n<li><strong>Fiyatland\u0131rma incelemesi<\/strong>: Artan k\u00fcresel ila\u00e7 fiyatland\u0131rmas\u0131 oda\u011f\u0131 k\u00e2rl\u0131l\u0131\u011f\u0131 etkileyebilir<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>G\u00fc\u00e7l\u00fc finansallar<\/strong>: <a href=\"https:\/\/stockanalysis.com\/stocks\/bmrn\/forecast\/\">2. \u00c7eyrek 2025 gelir beklentisi 62 milyon $ a\u015f\u0131ld\u0131<\/a> ve hisse ba\u015f\u0131na kazan\u00e7 tahminleri 0,51 $ ge\u00e7ti<\/li>\n<li><strong>\u00dcr\u00fcn hatt\u0131 ilerlemesi<\/strong>: Pozitif Faz 3 PALYNZIQ sonu\u00e7lar\u0131 ve tamamlanm\u0131\u015f VOXZOGO kayd\u0131<\/li>\n<li><strong>Stratejik sat\u0131n alma<\/strong>: 270 milyon $ de\u011ferinde Inozyme Pharma al\u0131m\u0131, enzim tedavisi portf\u00f6y\u00fcn\u00fc geni\u015fletti<\/li>\n<li><strong>Analist g\u00fcveni<\/strong>: <a href=\"https:\/\/www.directorstalkinterviews.com\/biomarin-pharmaceutical-inc-bmrn-stock-analysis-a-65-upside-potential-with-strong-buy-ratings\/4121210620\">22 analist AL \u00f6nerisini s\u00fcrd\u00fcr\u00fcyor<\/a> ve ortalama hedef fiyat 93,14 $<\/li>\n<li><strong>Sekt\u00f6r r\u00fczgarlar\u0131<\/strong>: Nadir hastal\u0131k tedavi pazar\u0131 y\u0131ll\u0131k %12 b\u00fcy\u00fcyor<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir Yat\u0131r\u0131mc\u0131 Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %2-5&#8217;ini temsil eden bir pozisyonla ba\u015flay\u0131n\u2014biyoteknoloji dikkatli risk y\u00f6netimi gerektirir<\/li>\n<li><strong>Dolar maliyeti ortalamas\u0131 yap\u0131n<\/strong>: Volatilite s\u0131ras\u0131nda zamanlama hatalar\u0131n\u0131 \u00f6nlemek i\u00e7in ayl\u0131k sabit tutarlarda yat\u0131r\u0131m yap\u0131n<\/li>\n<li><strong>Fiyat uyar\u0131lar\u0131 kurun<\/strong>: 4 Kas\u0131m kazan\u00e7lar\u0131 \u00e7evresinde BMRN&#8217;yi izleyin\u2014rapor sonras\u0131 %5-8 d\u00fc\u015f\u00fc\u015fte al\u0131m yap\u0131n<\/li>\n<li><strong>Uzun vadeli d\u00fc\u015f\u00fcn\u00fcn<\/strong>: BioMarin&#8217;in de\u011feri haftalar de\u011fil y\u0131llar i\u00e7inde ortaya \u00e7\u0131kar<\/li>\n<\/ol>\n<p><em>Mizahi deneyimli yat\u0131r\u0131mc\u0131 bilgeli\u011fi: &#8220;BMRN ticareti, boya kurumas\u0131n\u0131 izlemek gibidir\u2014ta ki \u00f6yle olmad\u0131\u011f\u0131 ana kadar. Biyoteknoloji sabr\u0131 oyunu amat\u00f6rleri, daha iyi boya alabilenlerden ay\u0131r\u0131r.&#8221;<\/em><\/p>\n<h2>\u2705 BioMarin Pharmaceutical Inc. (BMRN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>NASDAQ eri\u015fimi ve makul \u00fccretler sundu\u011fundan emin olun<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>Gerekli belgeleri sa\u011flay\u0131n\u2014genellikle 1-3 g\u00fcn s\u00fcrer<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Fon yat\u0131r\u0131n<\/td>\n<td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>G\u00fcncel fiyat\u0131 ara\u015ft\u0131r\u0131n<\/td>\n<td>Sipari\u015f vermeden \u00f6nce BMRN&#8217;nin ger\u00e7ek zamanl\u0131 fiyat\u0131n\u0131 kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>Giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Hisse miktar\u0131n\u0131 girin<\/td>\n<td>K\u00fc\u00e7\u00fck ba\u015fl\u0131yorsan\u0131z kesirli hisseleri d\u00fc\u015f\u00fcn\u00fcn<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>\u0130nceleyin ve onaylay\u0131n<\/td>\n<td>\u0130\u015flem \u00f6ncesi sipari\u015f detaylar\u0131n\u0131 \u00e7ift kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Pozisyonunuzu izleyin<\/td>\n<td>Fiyat hareketleri ve haberler i\u00e7in uyar\u0131lar kurun<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Uygun?<\/h2>\n<p>Pocket Option, hisse senedi yat\u0131r\u0131m\u0131n\u0131 herkes i\u00e7in eri\u015filebilir k\u0131lar:<\/p>\n<ul>\n<li><strong>Minimum depozito sadece 5 $<\/strong> \u2014 stratejileri d\u00fc\u015f\u00fck riskle test etmek i\u00e7in m\u00fckemmel<\/li>\n<li><strong>\u015eim\u015fek h\u0131z\u0131nda do\u011frulama<\/strong> \u2014 herhangi bir resmi kimlikle dakikalar i\u00e7inde ticarete ba\u015flay\u0131n<\/li>\n<li><strong>100&#8217;den fazla para \u00e7ekme y\u00f6ntemi<\/strong> \u2014 kripto paralar, e-c\u00fczdanlar ve banka transferleri dahil<\/li>\n<li><strong>Kullan\u0131c\u0131 dostu platform<\/strong> \u2014 piyasalar\u0131 \u00f6\u011frenen yeni ba\u015flayanlar i\u00e7in sezgisel aray\u00fcz<\/li>\n<\/ul>\n<h2>\ud83c\udf0d 2025&#8217;te BioMarin: Nadir Hastal\u0131k \u00d6nc\u00fcs\u00fc<\/h2>\n<p>BioMarin, yedi onayl\u0131 terapi ve sa\u011flam bir \u00fcr\u00fcn hatt\u0131yla nadir genetik hastal\u0131k tedavi pazar\u0131nda hakimdir. \u015eirketin d\u00fcnya \u00e7ap\u0131nda 5.000&#8217;den az hastay\u0131 etkileyen durumlara odaklanmas\u0131 do\u011fal tekel ve fiyatland\u0131rma g\u00fcc\u00fc yarat\u0131r. Yak\u0131n zamanda yapt\u0131\u011f\u0131 <a href=\"https:\/\/www.biomarin.com\/company\/\">270 milyon $ de\u011ferindeki Inozyme Pharma sat\u0131n al\u0131m\u0131<\/a>, enzim replasman tedavilerine agresif geni\u015flemeyi g\u00f6stermektedir.<\/p>\n<p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: BioMarin bilim insanlar\u0131, CLN2 tedavisinin sadece hastal\u0131k ilerlemesini yava\u015flatmakla kalmay\u0131p, ayn\u0131 zamanda genetik n\u00f6rolojik bozukluklarda daha \u00f6nce imkans\u0131z oldu\u011fu d\u00fc\u015f\u00fcn\u00fclen sinirsel rejenerasyon belirtileri g\u00f6sterdi\u011fini ke\u015ffettiler. Bu at\u0131l\u0131m, nadir hastal\u0131k tedavisine yakla\u015f\u0131m\u0131m\u0131z\u0131 devrim niteli\u011finde de\u011fi\u015ftirebilir.<\/p>\n"},"faq":[{"question":"BioMarin hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir ticaret platformu se\u00e7in, hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n, fon yat\u0131r\u0131n, g\u00fcncel fiyat\u0131 kontrol edin, sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in, hisse miktar\u0131n\u0131 girin, sipari\u015fi onaylay\u0131n ve pozisyonunuzu izleyin."},{"question":"BioMarin'in 2025-2030 fiyat tahmini nedir?","answer":"2025 y\u0131l sonunda 65-75 $, 2026'da 80-95 $, 2028'de 110-130 $ ve 2030'da 140-170 $ aral\u0131\u011f\u0131nda fiyatlar beklenmektedir."},{"question":"BioMarin hisseleri i\u00e7in temel riskler nelerdir?","answer":"D\u00fczenleyici belirsizlik, klinik deneme gecikmeleri, rekabet bask\u0131s\u0131 ve ila\u00e7 fiyatland\u0131rmas\u0131 \u00fczerindeki artan inceleme ba\u015fl\u0131ca risklerdir."},{"question":"Yeni ba\u015flayanlar BioMarin hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"K\u00fc\u00e7\u00fck ba\u015flay\u0131n, dolar maliyeti ortalamas\u0131 yap\u0131n, fiyat uyar\u0131lar\u0131 kurun ve uzun vadeli d\u00fc\u015f\u00fcn\u00fcn."},{"question":"Pocket Option yeni yat\u0131r\u0131mc\u0131lar i\u00e7in neden uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 do\u011frulama, \u00e7ok say\u0131da para \u00e7ekme y\u00f6ntemi ve kullan\u0131c\u0131 dostu platform sunar."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"BioMarin hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir ticaret platformu se\u00e7in, hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n, fon yat\u0131r\u0131n, g\u00fcncel fiyat\u0131 kontrol edin, sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in, hisse miktar\u0131n\u0131 girin, sipari\u015fi onaylay\u0131n ve pozisyonunuzu izleyin."},{"question":"BioMarin'in 2025-2030 fiyat tahmini nedir?","answer":"2025 y\u0131l sonunda 65-75 $, 2026'da 80-95 $, 2028'de 110-130 $ ve 2030'da 140-170 $ aral\u0131\u011f\u0131nda fiyatlar beklenmektedir."},{"question":"BioMarin hisseleri i\u00e7in temel riskler nelerdir?","answer":"D\u00fczenleyici belirsizlik, klinik deneme gecikmeleri, rekabet bask\u0131s\u0131 ve ila\u00e7 fiyatland\u0131rmas\u0131 \u00fczerindeki artan inceleme ba\u015fl\u0131ca risklerdir."},{"question":"Yeni ba\u015flayanlar BioMarin hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"K\u00fc\u00e7\u00fck ba\u015flay\u0131n, dolar maliyeti ortalamas\u0131 yap\u0131n, fiyat uyar\u0131lar\u0131 kurun ve uzun vadeli d\u00fc\u015f\u00fcn\u00fcn."},{"question":"Pocket Option yeni yat\u0131r\u0131mc\u0131lar i\u00e7in neden uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 do\u011frulama, \u00e7ok say\u0131da para \u00e7ekme y\u00f6ntemi ve kullan\u0131c\u0131 dostu platform sunar."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>BioMarin Pharmaceutical Inc. (BMRN) Hisseleri Nas\u0131l Al\u0131n\u0131r - BioMarin Pharmaceutical Inc. (BMRN) Hisse Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biomarin-pharmaceutical\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BioMarin Pharmaceutical Inc. (BMRN) Hisseleri Nas\u0131l Al\u0131n\u0131r - BioMarin Pharmaceutical Inc. (BMRN) Hisse Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biomarin-pharmaceutical\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T11:50:55+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biomarin-pharmaceutical\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biomarin-pharmaceutical\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"BioMarin Pharmaceutical Inc. (BMRN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; BioMarin Pharmaceutical Inc. (BMRN) Hisse Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-25T11:50:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biomarin-pharmaceutical\/\"},\"wordCount\":20,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biomarin-pharmaceutical\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biomarin-pharmaceutical\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biomarin-pharmaceutical\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biomarin-pharmaceutical\/\",\"name\":\"BioMarin Pharmaceutical Inc. (BMRN) Hisseleri Nas\u0131l Al\u0131n\u0131r - BioMarin Pharmaceutical Inc. (BMRN) Hisse Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biomarin-pharmaceutical\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biomarin-pharmaceutical\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp\",\"datePublished\":\"2025-08-25T11:50:55+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biomarin-pharmaceutical\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biomarin-pharmaceutical\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biomarin-pharmaceutical\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp\",\"width\":2560,\"height\":1429},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biomarin-pharmaceutical\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BioMarin Pharmaceutical Inc. (BMRN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; BioMarin Pharmaceutical Inc. (BMRN) Hisse Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"BioMarin Pharmaceutical Inc. (BMRN) Hisseleri Nas\u0131l Al\u0131n\u0131r - BioMarin Pharmaceutical Inc. (BMRN) Hisse Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biomarin-pharmaceutical\/","og_locale":"tr_TR","og_type":"article","og_title":"BioMarin Pharmaceutical Inc. (BMRN) Hisseleri Nas\u0131l Al\u0131n\u0131r - BioMarin Pharmaceutical Inc. (BMRN) Hisse Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biomarin-pharmaceutical\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T11:50:55+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biomarin-pharmaceutical\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biomarin-pharmaceutical\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"BioMarin Pharmaceutical Inc. (BMRN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; BioMarin Pharmaceutical Inc. (BMRN) Hisse Yat\u0131r\u0131m\u0131","datePublished":"2025-08-25T11:50:55+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biomarin-pharmaceutical\/"},"wordCount":20,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biomarin-pharmaceutical\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biomarin-pharmaceutical\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biomarin-pharmaceutical\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biomarin-pharmaceutical\/","name":"BioMarin Pharmaceutical Inc. (BMRN) Hisseleri Nas\u0131l Al\u0131n\u0131r - BioMarin Pharmaceutical Inc. (BMRN) Hisse Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biomarin-pharmaceutical\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biomarin-pharmaceutical\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp","datePublished":"2025-08-25T11:50:55+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biomarin-pharmaceutical\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biomarin-pharmaceutical\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biomarin-pharmaceutical\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp","width":2560,"height":1429},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biomarin-pharmaceutical\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"BioMarin Pharmaceutical Inc. (BMRN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; BioMarin Pharmaceutical Inc. (BMRN) Hisse Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":347370,"slug":"how-to-buy-biomarin-pharmaceutical","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu BioMarin Pharmaceutical Inc. (BMRN) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu BioMarin Pharmaceutical Inc. (BMRN)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-biomarin-pharmaceutical\/"},"pt_AA":{"locale":"pt_AA","id":347373,"slug":"how-to-buy-biomarin-pharmaceutical","post_title":"Como comprar a\u00e7\u00f5es da BioMarin Pharmaceutical Inc. (BMRN) - Investimento em a\u00e7\u00f5es da BioMarin Pharmaceutical Inc. (BMRN)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-biomarin-pharmaceutical\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/347375","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=347375"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/347375\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334117"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=347375"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=347375"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=347375"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}